Comparative proteomic analysis with postmortem prefrontal cortex tissues of suicide victims versus controls

Journal of Psychiatric Research

Volumn 41, Issue 6, 2007, Pages 493-501

  Schlicht, Katja ^a   Büttner, Andreas ^b   Siedler, Frank ^c   Scheffer, Bea ^c   Zill, Peter ^a   Eisenmenger, Wolfgang ^b   Ackenheil, Manfred ^a   Bondy, Brigitta ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

2D electrophoresis; Postmortem; Proteome; Serotonin; Suicide

Indexed keywords

ALPHA CRYSTALLIN; GENE PRODUCT; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; SEROTONIN;

ARTICLE; ASTROCYTE; AUTOPSY; CELL ACTIVATION; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NERVE DEGENERATION; NEUROBIOLOGY; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; PROTEOMICS; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE; SUICIDE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; VICTIM;

EID: 33846873669     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.04.006     Document Type: Article

References (35)

1. Anguelova M., Benkelfat C., and Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Molecular Psychiatry 8 (2003) 646-653
2. Bown C., Wang J.F., MacQueen G., and Young L.T. Increased temporal cortex ER stress proteins in depressed subjects who died by suicide. Neuropsychopharmacology 22 (2000) 327-332
3. De Leo M.E., Borrello S., Passantino M., Palazzotti B., Mordente A., Daniele A., et al. Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neuroscience Letters 250 (1998) 173-176
4. Derham B.K., Ellory J.C., Bron A.J., and Harding J.J. The molecular chaperone alpha-crystallin incorporated into red cell ghosts protects membrane Na/K-ATPase against glycation and oxidative stress. European Journal of Biochemistry 270 (2003) 2605-2611
5. Eng L.F., Ghirnikar R.S., and Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochemical Research 25 (2000) 1439-1451
6. Fatemi S.H., Laurence J.A., Araghi-Niknam M., Stary J.M., Schulz S.C., Lee S., and Gottesman I.I. Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. Schizophrenia Research 69 (2004) 317-323
7. Fountoulakis M., Hardmeier R., Hoger H., and Lubec G. Postmortem changes in the level of brain proteins. Experimental Neurology 167 (2001) 86-94
8. Gorg A., et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21 (2000) 1037-1053
9. Hynd M.R., Lewohl J.M., Scott H.L., and Dodd P.R. Biochemical and molecular studies using human autopsy brain tissue. Journal of Neurochemistry 85 (2003) 543-562
10. Inagaki M., Gonda Y., Nishizawa K., Kitamura S., Sato C., Ando S., et al. Phosphorylation sites linked to glial filament disassembly in vitro locate in a non-alpha-helical head domain. Journal of Biological Chemistry 265 (1990) 4722-4729
11. Jellinger K.A. Cell death mechanisms in Parkinson's disease. Journal of Neural Transmission 107 (2000) 1-29
12. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Molecular Psychiatry 5 (2000) 142-149
13. Kita T., Wagner G.C., and Nakashima T. Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. Journal Pharmacological Science 92 3 (2003) 178-195
14. Kuloglu M., Ustundag B., Atmaca M., Canatan H., Tezcan A.E., and Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochemistry & Function 20 (2002) 171-175
15. Liedtke W., Edelmann W., Bieri P.L., Chiu F.C., Cowan N.J., Kucherlapati R., et al. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17 (1996) 607-615
16. Mann J.J. Neurobiology of suicidal behaviour. Nature Reviews Neuroscience 4 (2003) 819-828
17. Michel T.M., Thome J., Martin D., Nara K., Zwerina S., Tatschner T., et al. Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis. Journal of Neural Transmission 111 (2004) 1191-1201
18. Monks T.J., Jones D.C., Bai F., and Lau S.S. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity. Therapeutic Drug Monitoring 26 (2004) 132-136
19. Nicholl I.D., and Quinlan R.A. Chaperone activity of alpha-crystallins modulates intermediate filament assembly. EMBO Journal 13 (1994) 945-953
20. Perkins D.N., Pappin D.J., Creasy D.M., and Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20 (1999) 3551-3567
21. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research 121 (2003) 109-122
22. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Analytical Chemistry 68 (1996) 850-858
23. Shinohara H., Inaguma Y., Goto S., Inagaki T., and Kato K. Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. Journal of the Neurological Sciences 119 (1993) 203-208
24. Si X., Miguel-Hidalgo J.J., O'Dwyer G., Stockmeier C.A., and Rajkowska G. Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology 29 (2004) 2088-2096
25. Tagliaferro P., Ramos A.J., Lopez E.M., Pecci S.J., and Brusco A. Neural and astroglial effects of a chronic parachlorophenylalanine-induced serotonin synthesis inhibition. Molecular and Chemical Neuropathology 32 (1997) 195-211
26. Tebbe A., Klein C., Bisle B., Siedler F., Scheffer B., and Garcia-Rizo C. Analysis of the cytosolic proteome of Halobacterium salinarum and its implication for genome annotation. Proteomics 5 1 (2005) 168-179 Ref Type: Magazine Article
27. van Heeringen K. The neurobiology of suicide and suicidality. Canadian Journal of Psychiatry 48 (2003) 292-300
28. van Noort J.M., van Sechel A.C., Bajramovic J.J., el Ouagmiri M., Polman C.H., Lassmann H., et al. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375 (1995) 798-801
29. van Rijk A.F., and Bloemendal H. Alpha-B-crystallin in neuropathology. Ophthalmologica 214 (2000) 7-12
30. Wang X.F., Wang D., Zhu W., Delrahim K.K., Dolnak D., and Rapaport M.H. Studies characterizing 60 kda autoantibodies in subjects with schizophrenia. Biological Psychiatry 53 (2003) 361-375
31. Webster M.J., Knable M.B., Johnston-Wilson N., Nagata K., Inagaki M., and Yolken R.H. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain, Behaviour and Immunity 15 (2001) 388-400
32. Wilkins M.R., Sanchez J.C., Gooley A.A., Appel R.D., Humphery-Smith I., Hochstrasser D.F., et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnology and genetic engineering Reviews 13 (1996) 19-50
33. Yamamoto M., Suhara T., Okubo Y., Ichimiya T., Sudo Y., Inoue M., et al. Age-related decline of serotonin transporters in living human brain of healthy males. Life Sciences 71 (2002) 751-757
34. Yao J.K., Reddy R.D., and van Kammen D.P. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15 (2001) 287-310
35. Zill P., Buttner A., Eisenmenger W., Moller H.J., Bondy B., and Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biological Psychiatry 56 (2004) 581-586